These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30545834)

  • 21. Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.
    Pantin J; Tian X; Shah AA; Kurlander R; Ramos C; Cook L; Khuu H; Stroncek D; Leitman S; Barrett J; Donohue T; Young NS; Geller N; Childs RW
    Am J Hematol; 2013 Oct; 88(10):874-82. PubMed ID: 23813900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
    Yucel OK; Saliba RM; Rondon G; Ahmed S; Alousi A; Bashir Q; Ciurea SO; Popat U; Khouri I; Marin D; Rezvani K; Kebriaei P; Shpall EJ; Champlin RE; Oran B
    Cancer; 2017 Jul; 123(14):2661-2670. PubMed ID: 28324640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.
    Keller JW; Andreadis C; Damon LE; Kaplan LD; Martin TG; Wolf JL; Ai WZ; Venstrom JM; Smith CC; Gaensler KM; Hwang J; Olin RL
    J Geriatr Oncol; 2014 Jul; 5(3):238-44. PubMed ID: 24894413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.
    El-Bietar J; Warren M; Dandoy C; Myers KC; Lane A; Wallace G; Davies SM; Jodele S
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1994-2001. PubMed ID: 26150023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.
    Buchbinder D; Nugent DJ; Brazauskas R; Wang Z; Aljurf MD; Cairo MS; Chow R; Duncan C; Eldjerou LK; Gupta V; Hale GA; Halter J; Hayes-Lattin BM; Hsu JW; Jacobsohn DA; Kamble RT; Kasow KA; Lazarus HM; Mehta P; Myers KC; Parsons SK; Passweg JR; Pidala J; Reddy V; Sales-Bonfim CM; Savani BN; Seber A; Sorror ML; Steinberg A; Wood WA; Wall DA; Winiarski JH; Yu LC; Majhail NS
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1776-84. PubMed ID: 22863842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation.
    Veeraputhiran M; Yang L; Sundaram V; Arai S; Lowsky R; Miklos D; Meyer E; Muffly L; Negrin R; Rezvani A; Shizuru J; Weng WK; Johnston L
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1744-1748. PubMed ID: 28668491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.
    Srinivasan R; Takahashi Y; McCoy JP; Espinoza-Delgado I; Dorrance C; Igarashi T; Lundqvist A; Barrett AJ; Young NS; Geller N; Childs RW
    Br J Haematol; 2006 May; 133(3):305-14. PubMed ID: 16643433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease.
    Vaughn JE; Gooley T; Maziarz RT; Pulsipher MA; Bhatia S; Maloney DG; Sandmaier BM; Flowers ME; Storb R; Sorror ML
    Br J Haematol; 2015 Nov; 171(3):411-6. PubMed ID: 26194447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
    Manabe A
    Int J Hematol; 2016 Apr; 103(4):359. PubMed ID: 26899856
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
    Wang CY; Ren HY; Qiu ZX; Wang Y; Cen XN; Wang LH; Wang MJ; Xu WL; Wang WS; Li Y; Dong YJ; Ou JP; Liang ZY; Liu W; Wang Q
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):659-63. PubMed ID: 23978015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.
    Alter BP; Giri N; Savage SA; Rosenberg PS
    Haematologica; 2018 Jan; 103(1):30-39. PubMed ID: 29051281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
    Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia.
    Ngwube A; Hayashi RJ; Murray L; Loechelt B; Dalal J; Jaroscak J; Shenoy S
    Pediatr Blood Cancer; 2015 Jul; 62(7):1270-6. PubMed ID: 25755151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34
    Barba P; Ratan R; Cho C; Ceberio I; Hilden P; Devlin SM; Maloy MA; Barker JN; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Ponce DM; Sauter C; Tamari R; van den Brink MRM; Young JW; O'Reilly RJ; Giralt SA; Perales MA
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):67-74. PubMed ID: 27789361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
    Maury S; Balère-Appert ML; Chir Z; Boiron JM; Galambrun C; Yakouben K; Bordigoni P; Marie-Cardine A; Milpied N; Kanold J; Maillard N; Socié G;
    Haematologica; 2007 May; 92(5):589-96. PubMed ID: 17488681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic Cell Transplantation-Comorbidity Index Score Is Correlated with Treatment-Related Mortality and Overall Survival following Second Allogeneic Hematopoietic Cell Transplantation in Children.
    Forlanini F; Zinter MS; Dvorak CC; Bailey-Olson M; Winestone LE; Shimano KA; Higham CS; Melton A; Chu J; Kharbanda S
    Transplant Cell Ther; 2022 Mar; 28(3):155.e1-155.e8. PubMed ID: 34848362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.
    Burroughs LM; Shimamura A; Talano JA; Domm JA; Baker KK; Delaney C; Frangoul H; Margolis DA; Baker KS; Nemecek ER; Geddis AE; Sandmaier BM; Deeg HJ; Storb R; Woolfrey AE
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1669-1677. PubMed ID: 28602958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
    Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative Telomere Length before Hematopoietic Cell Transplantation and Outcome after Unrelated Donor Hematopoietic Cell Transplantation for Acute Leukemia.
    Wang Y; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Lee SJ; Savage SA; Gadalla SM
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1054-1058. PubMed ID: 28389255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced-intensity conditioning (RIC) in children with nonmalignant disorders (NMD) undergoing unrelated donor umbilical cord blood transplantation (UCBT).
    Parikh S; Szabolcs P
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S53-5. PubMed ID: 22226113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.